Prodoxican indications
Oral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: 20 mg as a single dose, taken at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest possible duration.
Parenteral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: Initially, 20 mg IM/IV as a single dose given for 1-2 days, to be continued w/ the oral form, administered at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest duration.
Reconstitution: Dissolve lyophilisate in 2 mL of sterile water for inj.
Uses of Prodoxican in details
Prodoxican is used to reduce pain and inflammation (swelling) of the muscles, tendons, and joints in diseases like arthritis or in short-term injuries, strains, or sprains.
Prodoxican description
Novo-Prodoxican, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.
Prodoxican dosage
Oral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: 20 mg as a single dose, taken at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest possible duration.
Parenteral
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: Initially, 20 mg IM/IV as a single dose given for 1-2 days, to be continued w/ the oral form, administered at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest duration.
Reconstitution: Dissolve lyophilisate in 2 mL of sterile water for inj.
Prodoxican interactions
FELDENE is highly protein bound, and therefore, might be expected to displace other protein-bound drugs. Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs.
Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels.
Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. It is recommended that plasma lithium levels be monitored when initiating, adjusting and discontinuing FELDENE.
Prodoxican side effects
Cardiovascular
Edema; weight gain; CHF; alterations in BP; vasodilation; palpitations; tachycardia.
CNS
Headache; malaise; dizziness; somnolence; vertigo; depression; insomnia; nervousness.
Dermatologic
Pruritus; rash; sweating; erythema; bruising; desquamation; erythema multiforme; toxic epidermal necrolysis.
EENT
Tinnitus; swollen eyes; blurred vision; eye irritation; rhinitis; pharyngitis.
GI
Epigastric distress; nausea; vomiting; anorexia; constipation; stomatitis; abdominal discomfort; diarrhea; flatulence; abdominal pain; indigestion; toxicity (bleeding, ulceration, perforation); heartburn; dyspepsia; anorexia.
Genitourinary
Hematuria; proteinuria; increased BUN and serum creatinine; acute renal insufficiency and failure; papillary necrosis; interstitial nephritis; nephrotic syndrome; hyperkalemia; hyponatremia.
Hematologic
Increased bleeding time; decreased Hgb and Hct; anemia; leukopenia; eosinophilia, thrombocytopenia.
Hepatic
Increased LFTs; elevated liver enzymes.
Respiratory
Bronchospasm; laryngeal edema; dyspnea; hemoptysis; shortness of breath.
Prodoxican contraindications
Hypersensitivity to Prodoxican, aspirin or other NSAIDs. History of or active peptic ulceration, GI bleeding (melaena, haematemesis) or severe gastritis; severe heart failure. Last trimester of pregnancy.
Active ingredient matches for Prodoxican:
Tenoxicam in Brazil.
List of Prodoxican substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Portonal (Greece) | |
| Pycitil (Vietnam) | |
| Pycitil 20 mg x 1 Bottle in 1 tube dung mobi | |
| Pycityl (Vietnam) | |
| Pycityl 20 mg x 1 Bottle boät | |
| Pycityl 20 mg x 1 Box 1 Bottle | |
| Recaflex (Chile) | |
| Redac (Greece) | |
| Redac 25mg Combi-Pack / 1 (Ritz Pharma) | $ 0.71 |
| Redac 50mg Combi-Pack / 1 (Ritz Pharma) | $ 1.14 |
| 25 mg x 1's (Ritz Pharma) | $ 0.71 |
| 50 mg x 1's (Ritz Pharma) | $ 1.14 |
| REDAC inj 25 mg x 1ml (Ritz Pharma) | $ 0.71 |
| REDAC inj 50 mg x 1ml (Ritz Pharma) | $ 1.14 |
| Reutenox (Spain) | |
| Revianox (Georgia) | |
| Rheuflex (Philippines) | |
| Rheuflex 20 mg x 100's (Goldcrest) | |
| Rodix (Colombia) | |
| Rucornart (Japan) | |
| Seftil (Malaysia, Thailand) | |
| Seftil 20 mg x 25 x 10's (Unison) | |
| Seftil 20 mg x 10 x 10's (Unison) | |
| Seftil FC tab 20 mg 25 x 10's (Unison) | |
| Sinoral (Thailand) | |
| Sinoral 20 mg x 25 x 10's (Biolab) | |
| Soral (Greece) | |
| Sutondin (Taiwan) | |
| Sutondin 10 mg | |
| Sutondin 20 mg x 1000's | |
| Tecam (Venezuela) | |
| Teconam (Thailand) | |
| Teconam 20 mg x 500's (Asian pharm) | |
| Tefarel (Ecuador) | |
| Teflan (Brazil) | |
| Teksamen (Georgia) | |
| Teksamen-L (Georgia) | |
| Tenalgin (Portugal) | |
| Tenax (Thailand) | |
| Tenax 20 mg x 100's (Siam Bheasach) | |
| Tenax 20 mg x 500's (Siam Bheasach) | |
| Tenax FC tab 20 mg 10 x 10's (Siam Bheasach) | |
| Tencam (Taiwan) | |
| Tencam 20 mg x 100's | |
| Tencam 20 mg x 10's | |
| Tenikam (Georgia) | |
| Tenobio (Brazil) | |
| Tenocam (South Korea, Thailand) | |
| Tenocam 20 mg x 250's (Eurofarma) | |
| Tenogesic (Thailand) | |
| Tenogesic 20 mg x 10 x 10's | |
| Tenoksan (Turkey) | |
| Tenoktil (Turkey, Yemen) | |
| Tenoliof (Georgia) | |
See 243 substitutes for Prodoxican | |
References
- PubChem. "tenoxicam". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "tenoxicam". http://www.drugbank.ca/drugs/DB00469 (accessed September 17, 2018).
- DTP/NCI. "tenoxicam: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Prodoxican are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Prodoxican. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
